“…However, recent studies have highlighted the clinical significance of these non-falciparum species [ [8] , [9] , [10] ]. Both P. malariae and P. ovale have been implicated in major disease presentations such as severe anaemia, kidney-related complications, respiratory distress, hypotension, severe thrombocytopenia, jaundice, hepatomegaly, and hepatic dysfunction with possible fatal outcomes [ 9 , [11] , [12] , [13] , [14] , [15] ]. In addition, recent reports indicate an increasing prevalence of P. malariae and P. ovale in settings where P. falciparum transmission is decreasing [ 8 , [16] , [17] , [18] ].…”